Customized and fully aligned to your commercialization strategy
At Bora, we take pride in customizing our services to fit our client’s needs. Our integrated small-scale and pilot capabilities directly scale to our clinical and commercial equipment facilitating a seamless transition for your scale-up activities. Our dedicated R&D teams utilize small-scale development capabilities to effectively minimize API usage while optimizing formulation and process development before moving to large-scale pivotal or commercial manufacturing and packaging.
Dedicated suites for flexible small-scale cGMP manufacturing
At Bora’s North American sites in Mississauga, Ontario and Maple Grove, Minnesota, we operate dedicated suites for small-scale cGMP manufacturing with capacities ranging from 2.5 kg to 125 kg. The suites can accommodate a variety of dosage forms – solid oral (tablets & capsules), semi-solids (creams, gels, ointments), and liquids (liquids, suspensions and nasal sprays) – as well as high-potency APIs and DEA controlled substances. We also offer small-scale filling (in tubes and bottles), packaging, and serialization services.
